Lovells has strengthened its life sciences group with the addition of former Merck Sharp & Dohme legal director Marc Dalby, a client of the firm.
At Merck Sharp & Dohme, the UK subsidiary of Merck & Co, Dalby was company secretary in addition to his role as legal director. He has not been replaced yet.
Dalby joined the City firm today as a consultant in the life sciences team. He has a particular focus on the regulation of pharmaceutical promotion, competition law, product liability and data exclusivity.
Dalby has been a longstanding member of the legal affairs committee of the Association of the British Pharmaceutical Industry (ABPI) and has sat on a number of ABPI working groups and sub-committees.
He was called to the bar in 1986 and went on to practice at 5 King’s Bench Walk. He has also held legal positions at Lloyd’s of London and Napp Pharmaceuticals.